AnaptysBio Announces Positive Top-Line Proof-of-Concept Data For ANB020 In Moderate-to-Severe Baseline
pharmaceutical investing Sienna Biopharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results
Immune Design Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update
pharmaceutical investing Clearside Biomedical Announces Fourth Quarter 2017 Financial Results and Provides Corporate Update
pharmaceutical investing Xenon Pharmaceuticals Reports 2017 Financial Results and Provides Corporate Update
pharmaceutical investing Foamix Reports Fiscal Year 2017 Financial Results and Provides Corporate Update
Blue Jay Gold Announces Closing of Private Placement With Ocean Partners for Proceeds of $3.0 Million
Ucore Receives Louisiana Air Permit Covering Full 9,600 tpa Build-Out of Its Strategic Metals Complex
QIMC Sets Out Five-Phase Plan to Test Hydrogen Extraction at Bennett Hill, Nova Scotia, on the Path to Commercialization